Megestil (Megestrol Acetate)

Megestrol acetate binds to intracellular progesterone receptors, producing antigonadotropic effects that lower estrogen and androgen levels. It also has glucocorticoid‑like activity, which stimulates appetite and protein synthesis, thereby counteracting catabolic states and influencing hormone‑driven tumor growth.

The appropriate dose of Megestil is individualized by the prescribing clinician based on the specific indication, severity of the condition, patient weight, renal and hepatic function, and any concomitant therapies. Dosage regimens are not standardized and should follow the prescriber’s written order.

The safety of megestrol acetate in pregnancy and lactation has not been established. Because the drug can affect hormonal balance, it is generally avoided in pregnant or nursing women unless the potential benefit outweighs the potential risk, as determined by a qualified health professional.

To order Megestil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Megestil (megestrol acetate) is a progestogenic appetite stimulant, whereas other cachexia therapies may include corticosteroids, ghrelin mimetics, or nutritional interventions. Compared with corticosteroids, megestrol often provides longer‑lasting appetite improvement with a different side‑effect profile, but individual response varies and treatment choice depends on patient factors.

Megestil tablets should be stored at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Megestil is taken orally, usually with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, significant hyperglycemia that may require medical intervention, and severe allergic reactions including anaphylaxis. Patients should seek immediate medical attention if they experience sudden swelling, shortness of breath, high blood sugar symptoms, or signs of an allergic reaction.

Megestil is contraindicated in individuals with known hypersensitivity to megestrol acetate or any excipients, in patients with active thromboembolic disease, uncontrolled diabetes, or severe liver dysfunction. It should also be used with caution in patients receiving other hormonal agents or anticoagulants, and only under medical supervision.